1. Ravindran, Ethiraj, Arashiki, Nobuto, Becker, Lena-Luise, Nakamura, Fumio, Kaindl, Angela M. 2022. Monoallelic CRMP1 gene variants cause neurodevelopmental disorder. In eLife, 11, . doi:10.7554/eLife.80793. https://pubmed.ncbi.nlm.nih.gov/36511780/
2. Lukomska, Agnieszka, Theune, William C, Xing, Jian, Gupta, Mahit, Trakhtenberg, Ephraim F. 2023. Experimental gene expression of developmentally downregulated Crmp1, Crmp4, and Crmp5 promotes axon regeneration and retinal ganglion cell survival after optic nerve injury. In Brain research, 1809, 148368. doi:10.1016/j.brainres.2023.148368. https://pubmed.ncbi.nlm.nih.gov/37059258/
3. Li, Kay Ka-Wai, Qi, Yan, Xia, Tian, Lau, Kin-Mang, Ng, Ho-Keung. 2015. CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1. In PloS one, 10, e0127910. doi:10.1371/journal.pone.0127910. https://pubmed.ncbi.nlm.nih.gov/26009886/
4. Makihara, Hiroko, Nakai, Shiori, Ohkubo, Wataru, Kolattukudy, Pappachan, Goshima, Yoshio. 2016. CRMP1 and CRMP2 have synergistic but distinct roles in dendritic development. In Genes to cells : devoted to molecular & cellular mechanisms, 21, 994-1005. doi:10.1111/gtc.12399. https://pubmed.ncbi.nlm.nih.gov/27480924/
5. Akinaga, Satoshi, Harada, Sayaka, Takahashi, Miyuki, Goshima, Yoshio, Ohshima, Toshio. 2022. Loss of CRMP1 and CRMP2 results in migration defects of Purkinje cells in the X lobule of the mouse cerebellum. In Brain research, 1783, 147846. doi:10.1016/j.brainres.2022.147846. https://pubmed.ncbi.nlm.nih.gov/35219721/
6. Da Silva, Jorge Diogo, Soares, Ana Rita, Fortuna, Ana Maria, Tkachenko, Nataliya. 2023. Establishing an objective clinical spectrum, genotype-phenotype correlations, and CRMP1 as a modifier in the Ellis-van Creveld syndrome: The first systematic review of EVC- and EVC2-associated conditions. In Genetics in medicine open, 1, 100781. doi:10.1016/j.gimo.2023.100781. https://pubmed.ncbi.nlm.nih.gov/39669252/
7. Cai, G, Wu, D, Wang, Z, Chan, F L, Yu, S. 2016. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization. In Oncogene, 36, 546-558. doi:10.1038/onc.2016.227. https://pubmed.ncbi.nlm.nih.gov/27321179/
8. Luo, Jianguo, Chen, Shaojun, Chen, Jingsen, He, Fei, Wang, Enli. 2022. Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer. In PloS one, 17, e0278270. doi:10.1371/journal.pone.0278270. https://pubmed.ncbi.nlm.nih.gov/36454866/